Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-012225
Filing Date
2022-05-13
Accepted
2022-05-13 07:30:32
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20220331_10q.htm   iXBRL 10-Q 663859
2 EXHIBIT 31.1 ex_364549.htm EX-31.1 12898
3 EXHIBIT 31.2 ex_364550.htm EX-31.2 12938
4 EXHIBIT 32.1 ex_364551.htm EX-32.1 7352
10 picture1.jpg GRAPHIC 3521
  Complete submission text file 0001437749-22-012225.txt   3621335

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA plxp-20220331.xsd EX-101.SCH 32693
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20220331_cal.xml EX-101.CAL 33590
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20220331_def.xml EX-101.DEF 250051
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20220331_lab.xml EX-101.LAB 243247
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20220331_pre.xml EX-101.PRE 266465
41 EXTRACTED XBRL INSTANCE DOCUMENT plxp20220331_10q_htm.xml XML 451173
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 22920241
SIC: 2834 Pharmaceutical Preparations